Engineered Wnt7a ligands rescue blood brain barrier and neurobehavioral deficits in a mouse model of COVID-19
Troy N. Trevino, A Fogel, Guliz Otkiran, Seshadri B. Niladhuri, Mark A. Sanborn, Jacob Class, Ali A. Almousawi, Benoît Vanhollebeke, Leon M. Tai, Jalees Rehman, Justin M. Richner, Sarah E. Lutz
This study shows engineered Wnt7a ligands improve blood brain barrier and neurobehavioral deficits in a SARS-CoV-2 infected mouse model.
Brain · Jan 31, 2024Peer-reviewedNeuroscience